Bioengineering calendar

-

Friday, August 23, 2019

Wednesday, October 30, 2019

    • 12:00 pm
    • 2310 Everitt Lab

    Microbial strains have been successfully engineered to produce a wide variety of chemical compounds, several of which have been commercialized. As new products are targeted for biological synthesis, yield is frequently considered a primary driver towards determining feasibility. Theoretical yields can be calculated, establishing an upper limit on the potential conversion

Wednesday, March 11, 2020

    • 11:00 am
    • 2310 Everitt Lab

    Biologics, products produced from living organisms, have revolutionized treatment of disease. Examples of FDA-approved biologics include therapeutic proteins (e.g. blood clotting factors and antibodies), engineered viruses for gene therapy, and cell therapies. Biologics are addressing previous unmet medical needs, but are challenging to manufacture and therefore high in co

Tuesday, April 7, 2020